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Five Novel Mutations in Tyrosinase Gene of Japanese and Indian
Patients with Oculocutaneous Albinism Type I (OCA1)
To the Editor:
Oculocutaneous albinism (OCA), an autosomal recessive
disorder, is characterized by hypomelanosis in most tissues
including the skin, hair, and eyes, accompanied by reduced
visual acuity with photophobia and nystagmus, and it can
be separated into four types: type I, type II, type III, and type
IV OCA. Type I OCA (OCA1) is the most common type
caused by a mutation of the tyrosinase gene. The pheno-
type of OCA1 is white skin and hair, and red eyes because
tyrosinase activity is completely lacking, and melanin for-
mation never occurs throughout the patient’s life. In rare
cases of OCA1, the yellow pigment rapidly develops in the
white hair in the first few years of life, as the tyrosinase
activity is greatly decreased but not completely abolished
according to the site of the mutation of the tyrosinase gene
(King et al, 1995). Tyrosinase is a copper-containing enzyme
that catalyzes the rate-limiting first two steps in the melanin
biosynthetic pathway. The human tyrosinase gene, encod-
ing 529 amino acids, consists of five exons spanning more
than 50 kb of the DNA (Shibahara et al, 1988; Takeda et al,
1989) in chromosome 11q14–q21 (Barton et al, 1988). In
1989, we reported a pathologic mutation of the tyrosinase
gene in an OCA1 patient (Tomita et al, 1989). Since then, we
have continued to analyze the tyrosinase genes of OCA
patients.
In this study, we examined one Japanese and five Indian
patients with OCA as summarized in Table I. Since patient 1
died before this study, blood samples of the parents were
analyzed. All patients showed the typical OCA1 phenotype.
Genomic DNA was extracted from peripheral blood sam-
ples collected from patients and their unaffected parents
using a Qiagen Blood DNA Kit (Qiagen, Hilden, Germany).
DNA fragments corresponding to the protein coding region,
exon/intron junction, and the proximal promoter region (up
to 379 bp from the coding region) of the tyrosinase gene
were amplified by polymerase chain reaction. And then, In-
dian samples were directly sequenced in both directions
using an ABI 373A DNA Sequencer (Applied Biosystems,
Foster City, California) (Nakamura et al, 2002). On the other
hand, Japanese samples were analyzed using a Beckman
CEQ2000XL Sequencing System (Beckman Coulter, Fuller-
ton, California) (Miyamura et al, in press). This study was
approved by the Ethics Committee of Nagoya University
School of Medicine. The study was conducted according
to the Declaration of Helsinki Principles. Participants gave
their written informed consent.
The mutations of the tyrosinase gene detected in this
study are summarized in Table I. We found five novel mu-
tations, C91S, K131E, G295R, G346V, and E398G, none of
which was found in the tyrosinase sequence databases we
recently established of normally pigmented populations of
Indians and Japanese (Miyamura et al, in press), and we
therefore considered that the five novel ones should be
pathogenic. Over 100 mutations and polymorphisms have
been listed in electronic mutation databases (Albinism Da-
tabase and Human Gene Mutation Database, albinismdb.
med.umn.edu and archive.uwcm.ac.uk/uwcm/mg/hgmd0.
html), and 53 novel DNA variations were recently reported
(Opitz et al, 2004). Among the many mutations reported,
there are prevalent mutations and polymorphisms accord-
ing to each ethnic group. For example, P81L and T373K
Table I. Summary of OCA patients and their mutations
Patient
no. Sex Consanguinity Age
Ethnic
group
Clinical
feature
(hair/skin)
Tyrosinase gene mutation (paternal/maternal)
DiagnosisNucleotide change Amino acid change
1 F — Died at 21d Indian White/white c.272G4Ca/c.1254G4A p.C91Sa/p.G419R OCA1
2 F — 2 mo Indian White/white c.391A4Ga/c.832C4T p.K131Ea/p.R278X OCA1
3 M — Adult Indian White/white c.883G4Aa/c.832C4T p.G295Ra/p.R278X OCA1
4 M — 10 mo Indian White/white c.832C4T/c.1037G4Ta p.R278X/p.G346Va OCA1
5 F — 3 y Indian White/white c.1037G4Ta/c.832C4T p.G346Va/p.R278X OCA1
6 F — 6 mo Japanese White/white c.1193A4Ga/c.230G4A p.E398Ga/p.R77Q OCA1
aNovel mutations detected in this study.
OCA, oculocutaneous albinism.
Abbreviation: OCA, oculocutaneous albinism
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were observed in 25%–30% of pathological alleles of OCA
patients in northern Europe (Spritz, 1993; Spritz et al, 1997),
and R77Q and c.929insC (P310insC) are common in Kore-
ans (Park et al, 1996, 1997) and Japanese (Tomita et al,
2000). Similarly, R278X may be common in Indians, be-
cause it was already reported in the Indian population
(Tripathi et al, 1993; Sundaresan et al, 2004) and a high
frequency was also shown in this study, i.e., four of five
Indian patients had the R278X allele (Table I).
Recently, genetic diseases have received increasing at-
tention. Identification of prevalent and/or novel OCA alleles
will greatly facilitate DNA-based diagnosis, prenatal diag-
nosis, and carrier screening of OCA.
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